Trial intelligence / Profile preview

Rosuvastatin and Caffeine on PORH

NCT00851175Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Mar 2009
Primary completion
Aug 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label trial of rosuvastatin in atherosclerosis and cardiovascular disease (CVD), sponsored by Radboud University Medical Center. Started Mar 2009; status: completed.

02

Drugs

rosuvastatin
03

Conditions

atherosclerosiscardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT00851175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00851175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call